Related references
Note: Only part of the references are listed.Berberine inhibits colorectal tumor growth by suppressing SHH secretion
Zhu-qing Shen et al.
ACTA PHARMACOLOGICA SINICA (2021)
DSTG: deconvoluting spatial transcriptomics data through graph-based artificial intelligence
Qianqian Song et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116
Muhammad Azizan Samad et al.
MOLECULES (2021)
scLM: Automatic Detection of Consensus Gene Clusters Across Multiple Single-cell Datasets
Qianqian Song et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
WNT/β-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis
Xueying Yang et al.
CELL DEATH & DISEASE (2021)
FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
Sebastien Relier et al.
NATURE COMMUNICATIONS (2021)
A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
Yun Cai et al.
FRONTIERS IN PHARMACOLOGY (2021)
Demethyleneberberine promotes apoptosis and suppresses TGF-β/Smads induced EMT in the colon cancer cells HCT-116
Zehao Wang et al.
CELL BIOCHEMISTRY AND FUNCTION (2021)
scGCN is a graph convolutional networks algorithm for knowledge transfer in single cell omics
Qianqian Song et al.
NATURE COMMUNICATIONS (2021)
Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery
Qiang Sun et al.
FRONTIERS IN PHARMACOLOGY (2021)
Berberine Represses beta-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells
Kanchan Vishnoi et al.
MOLECULAR PHARMACOLOGY (2021)
Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer
Jamal Hallajzadeh et al.
MEDICAL ONCOLOGY (2020)
The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches
Solomon Habtemariam
BIOMEDICINES (2020)
Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients
Silvia Ravera et al.
SCIENTIFIC REPORTS (2020)
Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma
Huiling Qu et al.
CANCER CELL INTERNATIONAL (2020)
Crystal structure-guided design of berberine-based novel chitinase inhibitors
Lei Chen et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Biological Activity of Berberine-A Summary Update
Anna Och et al.
TOXINS (2020)
Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
Dahua Fan et al.
CURRENT NEUROPHARMACOLOGY (2019)
Network Meta-Analysis of Chinese Herbal Injections Plus the FOLFOX Regimen for the Treatment of Colorectal Cancer in China
Dan Zhang et al.
INTEGRATIVE CANCER THERAPIES (2019)
N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling
Abhirami Visvanathan et al.
GENES (2019)
Pharmacological effects of berberine on mood disorders
Jie Fan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis
Changshui Zhuang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis
Mahdi Abbasian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cancer stem cells in colorectal cancer: a review
Matthew J. Munro et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification
Hengyou Weng et al.
CELL STEM CELL (2018)
Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells
H. Ruan et al.
ONCOGENE (2017)
Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer
Yue Pan et al.
JOURNAL OF CANCER (2017)
Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
Mathew C. Casimiro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells
Sangmin Kim et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Berberine induces selective apoptosis through the AMPK-mediated mitochondrial/caspase pathway in hepatocellular carcinoma
Xiaolong Yang et al.
MOLECULAR MEDICINE REPORTS (2013)
Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells
Lihong Wang et al.
PLOS ONE (2013)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Berberine Inhibited Radioresistant Effects and Enhanced Anti-Tumor Effects in the Irradiated-Human Prostate Cancer Cells
Jung-Mu Hur et al.
TOXICOLOGICAL RESEARCH (2010)
The role of traditional Chinese medicine in colorectal cancer treatment
K. Y. Tan et al.
TECHNIQUES IN COLOPROCTOLOGY (2008)
New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
A Cadoret et al.
ONCOGENE (2002)
Linking colorectal cancer to Wnt signaling
M Bienz et al.
CELL (2000)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
